查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1317763

荷爾蒙避孕藥市場：按荷爾蒙、避孕方法和最終用戶分類 - 全球預測 2023-2030

Hormonal Contraceptives Market by Hormone, Method, End-user - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年全球荷爾蒙避孕藥市場規模為171.9億美元，年複合成長率為6.74%，預計2030年將達271.9億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球荷爾蒙避孕藥市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1. 荷爾蒙避孕藥的全球市場規模和預測是多少？

2.在預測期內，COVID-19 影響全球荷爾蒙避孕藥市場的阻礙因素和影響有哪些？

3.在預測期內，全球荷爾蒙避孕藥市場需要投資哪些產品/細分市場/應用/領域？

4. 全球荷爾蒙避孕藥市場的競爭策略是什麼？

5. 全球荷爾蒙避孕藥市場的技術趨勢和法律規範是什麼？

6.全球荷爾蒙避孕藥市場主要供應商的市佔率是多少？

7. 哪些型態和策略性措施被認為適合進入全球荷爾蒙避孕藥市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 女性妊娠相關健康風險增加
      • 政府努力促進避孕藥具的使用
      • 線上提供口服避孕藥
    • 抑制因素
      • 荷爾蒙避孕藥的副作用
    • 機會
      • 研究創造高效避孕方法
      • 改善荷爾蒙避孕藥的廣告和行銷
    • 任務
      • 社會對荷爾蒙避孕藥的接受度有限
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 荷爾蒙避孕藥市場（按荷爾蒙）

  • 雄激素
  • 抗雄激素
  • 雌激素
  • 促性腺激素
  • 黃體素

第7章 荷爾蒙避孕藥市場：依方法分類

  • 複方口服避孕藥
  • 植入式避孕藥
  • 注射避孕藥
  • 在子宮內
  • 口服避孕藥
  • 經皮吸收貼片
  • 避孕環

第8章 荷爾蒙避孕藥市場：依最終用戶分類

  • 門診手術中心
  • 婦科中心
  • 居家護理
  • 醫院和診所

第9章 美洲激素避孕藥市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區荷爾蒙避孕藥市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲荷爾蒙避孕藥市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業

第13章上市公司名單

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-4103B31E067C

The Global Hormonal Contraceptives Market is forecasted to grow significantly, with a projected USD 17.19 billion in 2023 at a CAGR of 6.74% and expected to reach a staggering USD 27.19 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Hormonal Contraceptives Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Hormonal Contraceptives Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Hormone, market is studied across Androgens, Antiandrogens, Estrogens, Gonadotropins, and Progestogens. The Gonadotropins is projected to witness significant market share during forecast period.

Based on Method, market is studied across Combined Oral Contraceptives, Implanted Contraceptives, Injected Contraceptives, Intrauterine, Oral Contraceptives, Transdermal Patch, and Vaginal Ring. The Injected Contraceptives is projected to witness significant market share during forecast period.

Based on End-user, market is studied across Ambulatory Surgical Centers, Gynecology Centers, Homecare, and Hospitals & Clinics. The Hospitals & Clinics is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Hormonal Contraceptives Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Hormonal Contraceptives Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Hormonal Contraceptives Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Hormonal Contraceptives Market?

4. What is the competitive strategic window for opportunities in the Global Hormonal Contraceptives Market?

5. What are the technology trends and regulatory frameworks in the Global Hormonal Contraceptives Market?

6. What is the market share of the leading vendors in the Global Hormonal Contraceptives Market?

7. What modes and strategic moves are considered suitable for entering the Global Hormonal Contraceptives Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Hormonal Contraceptives Market, by Hormone, 2022 vs 2030
  • 4.3. Hormonal Contraceptives Market, by Method, 2022 vs 2030
  • 4.4. Hormonal Contraceptives Market, by End-user, 2022 vs 2030
  • 4.5. Hormonal Contraceptives Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing cases of pregnancy-related health risks in women
      • 5.1.1.2. Government initiatives to promote the use of contraceptives
      • 5.1.1.3. Availability of oral contraceptives online
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects of hormonal contraceptives
    • 5.1.3. Opportunities
      • 5.1.3.1. Research studies for producing highly effective contraceptive methods
      • 5.1.3.2. Improving advertisements and marketing of hormonal contraceptives
    • 5.1.4. Challenges
      • 5.1.4.1. Limited social acceptance of hormonal contraceptives
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Hormonal Contraceptives Market, by Hormone

  • 6.1. Introduction
  • 6.2. Androgens
  • 6.3. Antiandrogens
  • 6.4. Estrogens
  • 6.5. Gonadotropins
  • 6.6. Progestogens

7. Hormonal Contraceptives Market, by Method

  • 7.1. Introduction
  • 7.2. Combined Oral Contraceptives
  • 7.3. Implanted Contraceptives
  • 7.4. Injected Contraceptives
  • 7.5. Intrauterine
  • 7.6. Oral Contraceptives
  • 7.7. Transdermal Patch
  • 7.8. Vaginal Ring

8. Hormonal Contraceptives Market, by End-user

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Gynecology Centers
  • 8.4. Homecare
  • 8.5. Hospitals & Clinics

9. Americas Hormonal Contraceptives Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Hormonal Contraceptives Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Hormonal Contraceptives Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. HORMONAL CONTRACEPTIVES MARKET RESEARCH PROCESS
  • FIGURE 2. HORMONAL CONTRACEPTIVES MARKET SIZE, 2022 VS 2030
  • FIGURE 3. HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2022 VS 2030 (%)
  • FIGURE 5. HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2022 VS 2030 (%)
  • FIGURE 6. HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. HORMONAL CONTRACEPTIVES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. HORMONAL CONTRACEPTIVES MARKET DYNAMICS
  • FIGURE 9. HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. HORMONAL CONTRACEPTIVES MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. HORMONAL CONTRACEPTIVES MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. HORMONAL CONTRACEPTIVES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 5. HORMONAL CONTRACEPTIVES MARKET SIZE, BY ANDROGENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. HORMONAL CONTRACEPTIVES MARKET SIZE, BY ANTIANDROGENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. HORMONAL CONTRACEPTIVES MARKET SIZE, BY ESTROGENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. HORMONAL CONTRACEPTIVES MARKET SIZE, BY GONADOTROPINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. HORMONAL CONTRACEPTIVES MARKET SIZE, BY PROGESTOGENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 11. HORMONAL CONTRACEPTIVES MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTED CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTED CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. HORMONAL CONTRACEPTIVES MARKET SIZE, BY INTRAUTERINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. HORMONAL CONTRACEPTIVES MARKET SIZE, BY TRANSDERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. HORMONAL CONTRACEPTIVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. HORMONAL CONTRACEPTIVES MARKET SIZE, BY GYNECOLOGY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. HORMONAL CONTRACEPTIVES MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. HORMONAL CONTRACEPTIVES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. HORMONAL CONTRACEPTIVES MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 151. HORMONAL CONTRACEPTIVES MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 152. HORMONAL CONTRACEPTIVES MARKET LICENSE & PRICING